No Contribution of IP3-R(2) to disease phenotype in models of dilated cardiomyopathy or pressure overload hypertrophy

Circulation: Heart Failure

Volumn 6, Issue 2, 2013, Pages 318-325

  Cooley, Nicola ^a   Ouyang, Kunfu ^b   McMullen, Julie R ^a   Kiriazis, Helen ^a   Sheikh, Farah ^b   Wu, Wei ^b   Mu, Yongxin ^b   Du, Xiao Jun ^a   Chen, Ju ^b   Woodcock, Elizabeth A ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atrium; Dilated cardiomyopathy; Echocardiography; Experimental models of heart failure; Pressure overload

Indexed keywords

INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE EXPRESSION PROFILING; HEART ATRIUM ENLARGEMENT; HEART ATRIUM THROMBOSIS; HEART ELECTROPHYSIOLOGY; HEART HYPERTROPHY; HEART MUSCLE CONTRACTILITY; HEART SIZE; HEART VENTRICLE WALL; LUNG CONGESTION; MALE; MOUSE; NERVE BLOCK; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; DISEASE MODEL; ELECTROCARDIOGRAPHY; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; HEART BLOCK; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE; HEART VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; METABOLISM; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; TIME; TRANSGENIC MOUSE;

ANIMALS; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ELECTROCARDIOGRAPHY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOTYPE; HEART BLOCK; HEART FAILURE; HYPERTROPHY, LEFT VENTRICULAR; INOSITOL 1,4,5-TRISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MYOCARDIUM; PHENOTYPE; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN-SERINE-THREONINE KINASES; TIME FACTORS; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE; VENTRICULAR REMODELING;

MLCS; MLOWN;

EID: 84877266046     PISSN: 19413289     EISSN: 19413297     Source Type: Journal    
DOI: 10.1161/CIRCHEARTFAILURE.112.972158     Document Type: Article

References (41)

1. Go LO, Moschella MC, Watras J, Handa KK, Fyfe BS, Marks AR. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest. 1995;95:888-894.
2. Voelkers M, Salz M, Herzog N, Frank D, Dolatabadi N, Frey N, Gude N, Friedrich O, Koch WJ, Katus HA, Sussman MA, Most P. Orai1 and Stim1 regulate normal and hypertrophic growth in cardiomyocytes. J Mol Cell Cardiol. 2010;48:1329-1334.
3. Nakayama H, Bodi I, Maillet M, DeSantiago J, Domeier TL, Mikoshiba K, Lorenz JN, Blatter LA, Bers DM, Molkentin JD. The IP3 receptor regulates cardiac hypertrophy in response to select stimuli. Circ Res. 2010;107:659-666.
4. Woodcock EA, Grubb DR, Filtz TM, Marasco S, Luo J, McLeod- Dryden TJ, Kaye DM, Sadoshima J, Du XJ, Wong C, McMullen JR, Dart AM. Selective activation of the "b" splice variant of phospholipase Cbeta1 in chronically dilated human and mouse atria. J Mol Cell Cardiol. 2009;47:676-683.
5. Li X, Zima AV, Sheikh F, Blatter LA, Chen J. Endothelin-1-induced arrhythmogenic Ca2+ signaling is abolished in atrial myocytes of inositol-1,4,5-trisphosphate(IP3)-receptor type 2-deficient mice. Circ Res. 2005;96:1274-1281.
6. Woodcock EA, Matkovich SJ. Ins(1,4,5)P3 receptors and inositol phosphates in the heart-evolutionary artefacts or active signal transducers? Pharmacol Ther. 2005;107:240-251.
7. Marks AR. Cardiac intracellular calcium release channels: role in heart failure. Circ Res. 2000;87:8-11.
8. Wang BH, Du XJ, Autelitano DJ, Milano CA, Woodcock EA. Adverse effects of constitutively active alpha(1B)-adrenergic receptors after pressure overload in mouse hearts. Am J Physiol Heart Circ Physiol. 2000;279:H1079-H1086.
9. Yamda J, Ohkusa T, Nao T, Ueyama T, Yano M, Kobayashi S, Hamano K, Esato K, Matsuzaki M. Up-regulation of inositol 1,4,5 trisphosphate receptor expression in atrial tissue in patients with chronic atrial fibrillation. J Am Coll Cardiol. 2001;37:1111-1119.
10. Yamamoto S, Yang G, Zablocki D, Liu J, Hong C, Kim SJ, Soler S, Odashima M, Thaisz J, Yehia G, Molina CA, Yatani A, Vatner DE, Vatner SF, Sadoshima J. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J Clin Invest. 2003;111:1463-1474.
11. Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, Lawitts J, Cantley LC, Izumo S. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 2000;19:2537-2548.
12. Pretorius L, Du XJ, Woodcock EA, Kiriazis H, Lin RC, Marasco S, Medcalf RL, Ming Z, Head GA, Tan JW, Cemerlang N, Sadoshima J, Shioi T, Izumo S, Lukoshkova EV, Dart AM, Jennings GL, Mc- Mullen JR. Reduced phosphoinositide 3-kinase (p110alpha) activation increases the susceptibility to atrial fibrillation. Am J Pathol. 2009;175:998-1009.
13. Sheikh F, Ouyang K, Campbell SG, Lyon RC, Chuang J, Fitzsimons D, Tangney J, Hidalgo CG, Chung CS, Cheng H, Dalton ND, Gu Y, Kasahara H, Ghassemian M, Omens JH, Peterson KL, Granzier HL, Moss RL, McCulloch AD, Chen J. Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease. J Clin Invest. 2012;122:1209-1221.
14. Amirahmadi F, Turnbull L, Du XJ, Graham RM, Woodcock EA. Heightened alpha1A-adrenergic receptor activity suppresses ischaemia/reperfusion- induced Ins(1,4,5)P3 generation in the mouse heart: a comparison with ischaemic preconditioning. Clin Sci. 2008;114:157-164.
15. Pfaffl MW. A new mathematical model for relative quantification in realtime RT-PCR. Nucleic Acids Res. 2001;29:e45.
16. Cheng H, Kimura K, Peter AK, Cui L, Ouyang K, Shen T, Liu Y, Gu Y, Dalton ND, Evans SM, Knowlton KU, Peterson KL, Chen J. Loss of enigma homolog protein results in dilated cardiomyopathy. Circ Res. 2010;107:348-356.
17. Wilkins BJ, Molkentin JD. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem Biophys Res Commun. 2004;322:1178-1191.
18. Ai X, Curran JW, Shannon TR, Bers DM, Pogwizd SM. Ca2+/calmodulin- dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res. 2005;97:1314-1322.
19. Wehrens XH, Lehnart SE, Marks AR. Intracellular calcium release and cardiac disease. Annu Rev Physiol. 2005;67:69-98.
20. Wu X, Zhang T, Bossuyt J, Li X, McKinsey TA, Dedman JR, Olson EN, Chen J, Brown JH, Bers DM. Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling. J Clin Invest. 2006;116:675-682.
21. Ju YK, Liu J, Lee BH, Lai D, Woodcock EA, Lei M, Cannell MB, Allen DG. Distribution and functional role of inositol 1,4,5-trisphosphate receptors in mouse sinoatrial node. Circ Res. 2011;109:848-857.
22. Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr, Chien KR. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA. 1991;88:8277-8281.
23. Byrne MJ, Raman JS, Alferness CA, Esler MD, Kaye DM, Power JM. An ovine model of tachycardia-induced degenerative dilated cardiomyopathy and heart failure with prolonged onset. J Card Fail. 2002;8:108-115.
24. Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G, Léger J, Charpentier F, Christ T, Dobrev D, Escande D, Nattel S, Demolombe S. Human atrial ion channel and transporter subunit geneexpression remodeling associated with valvular heart disease and atrial fibrillation. Circulation. 2005;112:471-481.
25. Lamirault G, Gaborit N, Le Meur N, Chevalier C, Lande G, Demolombe S, Escande D, Nattel S, Léger JJ, Steenman M. Gene expression profile associated with chronic atrial fibrillation and underlying valvular heart disease in man. J Mol Cell Cardiol. 2006;40:173-184.
26. Harrison SN, Autelitano DJ, Wang BH, Milano C, Du XJ, Woodcock EA. Reduced reperfusion-induced Ins(1,4,5)P3 generation and arrhythmias in hearts expressing constitutively active alpha1B-adrenergic receptors. Circ Res. 1998;83:1232-1240.
27. Jacobsen AN, Du XJ, Lambert KA, Dart AM, Woodcock EA. Arrhythmogenic action of thrombin during myocardial reperfusion via release of inositol 1,4,5-triphosphate. Circulation. 1996;93:23-26.
28. Du XJ, Anderson KE, Jacobsen A, Woodcock EA, Dart AM. Suppression of ventricular arrhythmias during ischemia-reperfusion by agents inhibiting Ins(1,4,5)P3 release. Circulation. 1995;91:2712-2716.
29. Shoki M, Kawaguchi H, Okamoto H, Sano H, Sawa H, Kudo T, Hirao N, Sakata Y, Yasuda H. Phosphatidylinositol and inositolphosphatide metabolism in hypertrophied rat heart. Jpn Circ J. 1992;56:142-147.
30. Corr PB, Yamada KA, DaTorre SD. Modulation of alpha-adrenergic receptors and their intracellular coupling in the ischemic heart. Basic Res Cardiol. 1990;85(suppl 1):31-45.
31. Mouton R, Huisamen B, Lochner A. The effect of ischaemia and reperfusion on sarcolemmal inositol phospholipid and cytosolic inositol phosphate metabolism in the isolated perfused rat heart. Mol Cell Biochem. 1991;105:127-135.
32. Mouton R, Huisamen B, Lochner A. Increased myocardial inositol trisphosphate levels during alpha 1-adrenergic stimulation and reperfusion of ischaemic rat heart. J Mol Cell Cardiol. 1991;23:841-850.
33. Waldron RT, Innamorati G, Torres-Marquez ME, Sinnett-Smith J, Rozengurt E. Differential PKC-dependent and -independent PKD activation by G protein ? subunits of the Gq family: selective stimulation of PKD Ser autophosphorylation by Gq. Cell Signal. 2012;24:914-921.
34. Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science. 1992;258:607-614.
35. Lemonnier L, Trebak M, Putney JW Jr. Complex regulation of the TRPC3, 6 and 7 channel subfamily by diacylglycerol and phosphatidylinositol- 4,5-bisphosphate. Cell Calcium. 2008;43:506-514.
36. Woodcock EA, Kistler PM, Ju YK. Phosphoinositide signalling and cardiac arrhythmias. Cardiovasc Res. 2009;82:286-295.
37. Roberts R. Genomics and cardiac arrhythmias. J Am Coll Cardiol. 2006;47:9-21.
38. Bian JS, McDonald TV. Phosphatidylinositol 4,5-bisphosphate interactions with the HERG K(+) channel. Pflugers Arch. 2007;455:105-113.
39. Shears SB. Metabolism of inositol phosphates. Adv Second Messenger Phosphoprotein Res. 1992;26:63-92.
40. Stephens L, Radenberg T, Thiel U, Vogel G, Khoo KH, Dell A, Jackson TR, Hawkins PT, Mayr GW. The detection, purification, structural characterization, and metabolism of diphosphoinositol pentakisphosphate(s) and bisdiphosphoinositol tetrakisphosphate(s). J Biol Chem. 1993; 268:4009-4015.
41. Alcázar-Román AR, Wente SR. Inositol polyphosphates: a new frontier for regulating gene expression. Chromosoma. 2008;117:1-13.